Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Articles tagged with "Medication"

Opinion: Politics Should Not Trump Science in Medicine

John A. Goldman, MD  |  April 15, 2016

I tell my patients there are three types of science: 1) investigative science, which sometimes gets it right; 2) science in the courtroom, which is junk science; and 3) science in Washington, D.C., which is political science. Our decisions are based on art and science; our patients’ medications are brought to market based on science….

Older Americans Taking More Medications

Andrew M. Seaman  |  March 24, 2016

(Reuters Health)—The proportion of older Americans taking at least five medications or supplements went up in a recent study. The increase in people using multiple medications paralleled an increase in the number of older Americans at risk for major drug interactions, researchers found. “That’s a concern from a public health standpoint, because it’s getting worse,”…

Patients Steered to Fewer Pharmacies May Fill More Prescriptions

Lisa Rapaport  |  September 9, 2015

(Reuters Health)—When patients have drug benefits that encourage them to save money by using certain pharmacies, they may end up filling more prescriptions, a company-funded study suggests. Narrow pharmacy networks that cover prescriptions only at certain retailers and drug benefits that offer consumers lower out-of-pocket fees at a subset of preferred pharmacies have become more…

Personal Beliefs Affect Medication Adherence for RA Patients

Richard Quinn  |  July 10, 2015

A recent British study concluded that determining a rheumatoid arthritis patient’s personal beliefs about medication could aid rheumatologists in regularly addressing medication adherence during visits.

Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do

Jennifer Stichman, MD, and Dennis J. Boyle, MD  |  April 1, 2015

Lack of efficacy, poor DAS scores may be misinterpreted as a drug failure

Advice Rheumatologists Can Share with Patients Planning to Relocate, a Patient Perspective

Sarah Troxell, RN, BSN  |  April 1, 2015

Tips for stocking up on medications, providing comprehensive health history to new physicians and coping with stress

Can DIY Medicine Tame Rampaging Healthcare Costs?

Simon M. Helfgott, MD  |  April 1, 2015

High health insurance deductibles, physician charges, medication expenses spur patients to seek less costly lab testing, surgical procedures, prescription drugs

Prior Authorization Requests Delay or Prevent Delivery of Needed Meds

Richard Quinn  |  March 27, 2015

Rheumatologist denounces common practice as a time-draining impediment to patient care

Rheumatology Research Foundation Backs Need to Accelerate New Medicines for Lupus

Staff  |  November 1, 2014

Foundation appeals to Congressional lawmakers for support of biomedical innovation to battle lupus

Drug Diversion Concerns on the Rise

Kurt Ullman  |  September 5, 2012

Medications removed from legitimate supply channels can affect both physician and patient.

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences